IT:KMDA Kamada Ltd

Kamada Ltd is an orphan drug, plasma-derived protein therapeutics company and develops & produces specialty plasma-derived protein therapeutics. Its flagship product include Glassia.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol KMDA.

1,702.00 ILS
As of 09/23/2021


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Developed markets ex-US
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  Israel
Country of incorporation:  Israel
IPO date:  08/31/2005
Stock exchange:    Tel Aviv Stock Exchange
Exchange country:   Israel
Market cap:   75,977,687,040 ILS
Current dividend yield:   0.00%
CUSIP:    
ISIN:        IL0010941198
Sedol:      B0L2CR5

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy